http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0240481-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ccad9d13c18902f09663274557d076ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bfab3bbf074721e118b4797911c15da http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42fbe020e176c4687b438fa686a940de http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c84d12ecd73a6df0e7bbe70fd1e2376 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34 |
| filingDate | 2001-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a0367a94fedb259eb61e9a603397c00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bd628bd06aa81d4bdbf7ffd932d2749 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffb7b74b671bcf5a88b1fee0c23a4490 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_059b6fe9d9c481b9352ac782f7606c16 |
| publicationDate | 2003-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0240481-A3 |
| titleOfInvention | Adenine based inhibitors of adenylyl cyclase, pharmaceutical compositions and method of use thereof |
| abstract | The present invention relates to derivatives and analogues of adenine, which inhibit adenylyl cyclase activity. The present invention also relates to a method of preventing and inhibiting a patient's fibroporliferative vasculopathy following vascular injury or a vascular surgical operation which includes administering to the patient, an effective amount of a compound according to the invention subsequent to a vascular injury, or subsequent to a vascular surgical operation, for one to two weeks after the injury or surgical operation, effective to treat or prevent a patient's fibroproliferative vasculopathy such as chronic allorgraft rejection or vascular restenosis following vascular trauma. The present invention also relates to a method for measuring the inhibition of adenylyl cyclase activity and a method for treating congestive heart failure. |
| priorityDate | 2000-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 111.